Trade SNGX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Soligenix, Inc. (SNGX) is trading at US$0.38, down 0.84% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$8.73M. Over the past 52 weeks, SNGX has traded between US$0.28 and US$3.07. On Syfe you can trade SNGX with $0 commission and add it to your watchlist.
| Previous close | US$0.38 |
|---|---|
| Market cap | US$8.73M |
| 52-week range | US$0.28 – US$3.07 |
| Volume | 108.03K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Soligenix, Inc.
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.
Year: 1994
Top Premarket Gainers
May 27, 11:16 AM · MT Newswires
Soligenix, Inc. (SNGX) stock is trading at US$0.38, -0.84% from the previous close of US$0.38.
The market cap for Soligenix, Inc. (SNGX) stock is approximately US$8.73M.
The 52-week high for Soligenix, Inc. (SNGX) stock is US$3.07.
The 52-week low for Soligenix, Inc. (SNGX) stock is US$0.28.
Soligenix, Inc. (SNGX) does not currently pay a dividend.
Stay on top of SNGX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
